Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLASSIC: Basal vs Mid-Mixture Insulin in Chinese T2DM
NCT03018938Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Feb 2017
- Primary completion
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin lispro, insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Eli Lilly and Company. Started Feb 2017; status: completed.
02
Drugs
insulin lisproinsulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03018938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03018938.